---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-001862"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2025-05-19T23:59:59+00:00"
generated_at: "2026-05-21T01:40:08.869235+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lifeward appoints Mark Grant as President and CEO, effective June 2, 2025

## Summary
- Mark Grant will become CEO on June 2; Larry Jasinski serves as Co-CEO through June 30, then advisory through 2025.
- Grant received inducement option grant of 400,000 shares, vesting over 4 years, at closing price on grant date.
- Employment agreement includes $435,000 base salary, up to 70% annual bonus, and severance provisions.
- Grant brings 30 years of healthcare leadership, most recently as President of Americas at Medtronic and IMRA Surgical.
- Transition is planned; Jasinski will remain available on an as-needed basis through end of 2025.

## SEC filing metadata
- accession: 0001178913-25-001862
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2025-05-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891325001862/0001178913-25-001862-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891325001862/zk2533212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-001862
- JSON: https://secwatch.observer/filing/0001178913-25-001862.json
- Plain text: https://secwatch.observer/filing/0001178913-25-001862.txt

## Key facts
- Executive change
  Mark Grant was appointed as President and Chief Executive Officer at Lifeward Ltd..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: the Board of Directors (the “Board”) of Lifeward Ltd. (the “Company”) approved the appointment of Mark Grant as the Company’s President and Chief Executive Officer, effective June 2, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1607962/000117891325001862/0001178913-25-001862-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.